Comparison of add-on medications for persistent storage symptoms after α-blocker treatment in BPH patients – a network meta-analysis

BACKGROUND: Patients with benign prostatic hyperplasia (BPH) receive α-blockers as first-line therapy to treat lower urinary tract symptoms; however, some individuals still experience residual storage symptoms. Antimuscarinics, β3-agonists, and desmopressin are effective add-on medications. Neverthe...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yi-Ting, Chen, Hsiao-Ling, Teoh, Jeremy Yuen-Chun, Chan, Vinson Wai-Shun, Wu, Wen-Jeng, Lee, Hsiang-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546657/
https://www.ncbi.nlm.nih.gov/pubmed/37789333
http://dx.doi.org/10.1186/s12894-023-01327-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546657/
https://www.ncbi.nlm.nih.gov/pubmed/37789333
http://dx.doi.org/10.1186/s12894-023-01327-1

Ejemplares similares